EAGLE PHARMACEUTICALS

YTD

ALL

Why Robinhood?

You can watch EGRX and buy or sell other stocks, ETFs, and their options commission-free!

About EGRX

Eagle Pharmaceuticals, Inc. is a biotechnology pharmaceutical company, which focuses on developing and commercializing injectable products primarily in the metabolic critical care and oncology areas in the United States. Its products include RYANODEX, BENDEKA and BELRAPZO.

CEO

Michael Graves

CEOMichael Graves

Employees

135

Employees135

Headquarters

Woodcliff Lake, New Jersey

HeadquartersWoodcliff Lake, New Jersey

Founded

2007

Founded2007

Employees

135

Employees135

EGRX Key Statistics

Market cap

1.36M

Market cap1.36M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

6.03K

Average volume6.03K

High today

$0.105

High today$0.105

Low today

$0.105

Low today$0.105

Open price

$0.105

Open price$0.105

Volume

19.00

Volume19.00

52 Week high

$3.87

52 Week high$3.87

52 Week low

$0.0025

52 Week low$0.0025

People also own

Based on the portfolios of people who own EGRX. This list is generated using Robinhood data, and it’s not a recommendation.

EAGLE PHARMACEUTICALS

Why Robinhood?

Eagle Pharmaceuticals, Inc. is a biotechnology pharmaceutical company, which focuses on developing and commercializing injectable products primarily in the metabolic critical care and oncology areas in the United States. Its products include RYANODEX, BENDEKA and BELRAPZO. Show more

EGRX Key Statistics

People also own

Eagle Pharmaceuticals, Inc. is a biotechnology pharmaceutical company, which focuses on developing and commercializing injectable products primarily in the metabolic critical care and oncology areas in the United States. Its products include RYANODEX, BENDEKA and BELRAPZO.